Defined Benefit
Insurance Assets

3Q22 Private Equity Activity Dips but Reflects Pre-Pandemic Levels

3Q22 Private Equity Activity Dips but Reflects Pre-Pandemic Levels
2 min 30 sec

Private equity activity measures in 3Q22 fell from 2Q, although totals reflect reasonable pre-pandemic levels. The IPO market for both venture capital and buyouts increased but dollar volumes remained miniscule. The market is in the process of slowing from last year’s peak activity. Interest rate increases and price discovery are beginning to take hold and a risk-off sentiment appears to be building, with declining distributions leading the slowdown.

3Q22 Private Equity Activity in Detail

Fundraising: Based on preliminary data, private equity partnerships holding final closes in 3Q totaled $226 billion, with 484 new partnerships formed (unless otherwise noted, all data are from PitchBook). The dollar volume fell 6% from 2Q22, and the number of funds holding final closes declined 9%. So far, capital raised is running only 2% behind year-to-date (YTD) 2021, but the number of funds trails by 31%. The fundraising landscape is expected to slow further, as many investors are becoming over-allocated versus private equity target ranges due to large declines in asset owners’ public security portfolios.

3Q22 private equity

Buyouts: New buyout transactions and dollar volume fell moderately. Funds closed 2,881 company investments with $152 billion of disclosed deal value, a 10% decrease in count and a 7% drop in dollar value from 2Q22.

Venture Capital: New financing rounds in venture capital companies totaled 9,985, with $97 billion of announced value. The number of investments was down 17% from the prior quarter, and the announced value plunged 32%. The median pre-money valuations of Seed through Series B rounds increased but C and D rounds fell in YTD 2022 versus 2021 pricing.

Exits: There were 594 private M&A exits of private equity-backed companies (excluding venture capital), with disclosed values totaling $128 billion. Exits were down 3% from the prior quarter and announced dollar volume dropped 10%. The YTD exit count is down 24%. There were 62 private equity-backed IPOs in 3Q raising $11 billion, up from 46 totaling $7 billion in 2Q.

Venture-backed M&A exits totaled 520 transactions with disclosed value of $24 billion. The number of sales declined 26% but announced dollar volume fell only 4%. The YTD exit count dropped 19%. There were 104 VC-backed IPOs with a combined float of $15 billion. For comparison, 2Q had 81 IPOs and total issuance of $12 billion.

3q22 private equity

Returns: With the strong 2Q retreat in public equity markets, private equity outperformance has widened given private equity’s more gradual quarterly mark-to-market valuation methodology. While GPs have put forward persistently high valuations relative to public markets, continued declines are expected.


Certain information herein has been compiled by Callan and is based on information provided by a variety of sources believed to be reliable for which Callan has not necessarily verified the accuracy or completeness of or updated. This report is for informational purposes only and should not be construed as legal or tax advice on any matter. Any investment decision you make on the basis of this report is your sole responsibility. You should consult with legal and tax advisers before applying any of this information to your particular situation. Reference in this report to any product, service, or entity should not be construed as a recommendation, approval, affiliation, or endorsement of such product, service, or entity by Callan. Past performance is no guarantee of future results. This report may consist of statements of opinion, which are made as of the date they are expressed and are not statements of fact. The Callan Institute (the “Institute”) is, and will be, the sole owner and copyright holder of all material prepared or developed by the Institute. No party has the right to reproduce, revise, resell, disseminate externally, disseminate to subsidiaries or parents, or post on internal web sites any part of any material prepared or developed by the Institute, without the Institute’s permission. Institute clients only have the right to utilize such material internally in their business.

Posted by

Share on facebook
Share on twitter
Share on linkedin
Related Posts

A Deeper Look at How We Did With Our Capital Markets Assumptions

Julia Moriarty
An analysis of how Callan's Capital Markets Assumptions performed over time by asset class.
Private Markets

Significant Drops in Private Equity Activity From Peak Years of 2021-22

Ashley Kahn
Callan expert analyzes private equity activity in 1Q24, from fundraising to exits.
Private Markets

Sector-Specialist Strategies: What Institutional Investors Need to Know

Chrissy Mehnert
A look at sector-specialist strategies and how institutional investors can analyze them.
Private Markets

Private Equity Sees a Big Slowdown After Frenzy of 2021

Ashley Kahn
An update on private equity performance in 4Q23 and for the year.
Private Markets

Private Equity Investors Focus on Exits as Activity Drops

Alternatives Consulting Group
The Alternatives Consulting Group provides an update on private equity performance in 3Q23.

What Investors Need to Know About the SEC’s 2023 Private Funds Rules

Alternatives Consulting Group
The Alternatives Consulting Group analyzes the new SEC rules on unregistered private funds.
Private Markets

Private Equity Headwinds Slow Liquidity

Alternatives Consulting Group
Gary Robertson provides an update on private equity activity in 2Q23, from fundraising to exits.
Private Markets

Private Equity Starts Adjusting to Tighter Conditions

Alternatives Consulting Group
The Alternatives Consulting Group analyzes private equity activity, from fundraising to exits, in 1Q23.
Private Markets

Private Equity Decelerated in 2022, with the Outlook for 2023 Very Unclear

Alternatives Consulting Group
The Alternatives Consulting Group provides an overview of private equity activity in 4Q22 and for the full year.

Emerging Managers in Private Equity: A Guide for Success

David Smith
David Smith provides a guide for emerging managers that seek to receive institutional allocations for private equity investments.

Callan Family Office

You are now leaving Callan LLC’s website and going to Callan Family Office’s website. Callan Family Office is not affiliated with Callan LLC.  Callan LLC has licensed the Callan® trademark to Callan Family Office for use in providing investment advisory services to ultra-high net worth clients, family foundations, and endowments. Callan Family Office and Callan LLC are independent, unaffiliated investment advisory firms separately registered with the Securities and Exchange Commission under the Investment Advisers Act of 1940.

Callan LLC is not responsible for the services and content on Callan Family Office’s website. Inclusion of this link does not constitute or imply an endorsement, sponsorship, or recommendation by Callan LLC of their website, or its contents, and Callan LLC is not responsible or liable for your use of it. When visiting their website, you are subject to Callan Family Office’s terms of use and privacy policies.